The administration of tumor necrosis factor-α (TNF-α) inhibitors has been shown to restore the flow of intestinal substances obstructed by TLOs into the lymphatic vessels and to alleviate intestinal inflammation in ileitis mouse models [7]. This evidence concerns the gene TNF and Crohn ileitis.